EDESA BIOTECH, INC. Equity Method Investments
EDESA BIOTECH, INC. (EDSA) had Equity Method Investments of $0 as of 2019-03-31, per its 10-Q filed 2019-05-08.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:EquityMethodInvestments · last filed 2019-05-08
- 2019-03-31: Equity Method Investments $0.00.
- 2018-12-31: Equity Method Investments $0.00.
- 2018-09-30: Equity Method Investments $46.46K.
- 2018-06-30: Equity Method Investments $66.69K.
| Period end | Equity Method Investments |
|---|---|
| 2019-03-31 | $0.00 10-Q · filed 2019-05-08 |
| 2018-12-31 | $0.00 10-Q · filed 2019-02-05 |
| 2018-09-30 | $46.46K 10-Q · filed 2019-05-08 |
| 2018-06-30 | $66.69K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $66.69K 10-Q · filed 2018-05-07 |
| 2017-12-31 | $66.69K 10-Q · filed 2018-02-07 |
| 2017-09-30 | $66.69K 10-K · filed 2018-11-30 |
| 2017-06-30 | $66.69K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $66.69K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $66.69K 10-Q · filed 2017-02-06 |
| 2016-09-30 | $66.69K 10-K · filed 2017-12-01 |
| 2016-06-30 | $66.69K 10-Q · filed 2016-08-09 |
| 2015-09-30 | $0.00 10-K · filed 2016-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |